IPP Bureau
Supriya Lifesciences received GMP certification from ANVISA Brazil
By IPP Bureau - January 06, 2024
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Hyderabad to host 66th All India Congress of Obstetrics and Gynaecology 2024
By IPP Bureau - January 05, 2024
The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology
PayNearby, Star Health join forces to provide health cover to uninsured across Bharat
By IPP Bureau - January 05, 2024
Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors
Lupin receives tentative approval from USFDA for Dapagliflozin and Saxagliptin tablets
By IPP Bureau - January 04, 2024
Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US
Medway Hospitals raises US$5 million in a financing round led by Kyra Ventures
By IPP Bureau - January 04, 2024
Medway setup a state-of-the-art Heart Institute in Chennai
Mandaviya lays foundation stone for NCDC regional branch, state branches and 2 BSL-3 laboratories
By IPP Bureau - January 03, 2024
Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation
India screens 1 crore+ person for Sickle Cell Disease
By IPP Bureau - January 03, 2024
The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh
Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24
By IPP Bureau - January 03, 2024
The company has received five final approvals
Strides Pharma Science to invest in AMP-6, AMP-8
By IPP Bureau - January 03, 2024
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India
By IPP Bureau - January 03, 2024
Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs
Healthcare Triangle completes US$2 million private placement debt offering
By IPP Bureau - January 03, 2024
The company received gross proceeds of approximately US$1.7 million and net proceeds,
WuXi XDC partners with IntoCell to accelerate ADC discovery and development
By IPP Bureau - January 03, 2024
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases
By IPP Bureau - January 03, 2024
Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes